SE8602981D0 - Novel medicinal use - Google Patents

Novel medicinal use

Info

Publication number
SE8602981D0
SE8602981D0 SE8602981A SE8602981A SE8602981D0 SE 8602981 D0 SE8602981 D0 SE 8602981D0 SE 8602981 A SE8602981 A SE 8602981A SE 8602981 A SE8602981 A SE 8602981A SE 8602981 D0 SE8602981 D0 SE 8602981D0
Authority
SE
Sweden
Prior art keywords
medicinal use
novel medicinal
treatment
infections
formulawherein
Prior art date
Application number
SE8602981A
Other languages
English (en)
Inventor
B F H Eriksson
K N G Johansson
G B Stening
B R Oberg
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Priority to SE8602981A priority Critical patent/SE8602981D0/sv
Publication of SE8602981D0 publication Critical patent/SE8602981D0/sv
Priority to EP87904641A priority patent/EP0277151B1/en
Priority to AU77005/87A priority patent/AU598575B2/en
Priority to PCT/SE1987/000316 priority patent/WO1988000050A1/en
Priority to DE8787904641T priority patent/DE3773892D1/de
Priority to AT87904641T priority patent/ATE68349T1/de
Priority to JP62504153A priority patent/JP2540576B2/ja
Priority to CA000541194A priority patent/CA1286991C/en
Priority to DK198800927A priority patent/DK172617B1/da
Priority to US07/319,840 priority patent/US6358934B1/en
Priority to US08/118,356 priority patent/US5446029A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
SE8602981A 1986-07-04 1986-07-04 Novel medicinal use SE8602981D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8602981A SE8602981D0 (sv) 1986-07-04 1986-07-04 Novel medicinal use
JP62504153A JP2540576B2 (ja) 1986-07-04 1987-07-02 抗レトロウイルスおよびｂ型肝炎剤
DE8787904641T DE3773892D1 (de) 1986-07-04 1987-07-02 Medizinische verwendung von nukleosiden.
AU77005/87A AU598575B2 (en) 1986-07-04 1987-07-02 Retrovirus treatments
PCT/SE1987/000316 WO1988000050A1 (en) 1986-07-04 1987-07-02 Novel medicinal use of nucleosides
EP87904641A EP0277151B1 (en) 1986-07-04 1987-07-02 Novel medicinal use of nucleosides
AT87904641T ATE68349T1 (de) 1986-07-04 1987-07-02 Medizinische verwendung von nukleosiden.
CA000541194A CA1286991C (en) 1986-07-04 1987-07-03 Medicament for the treatment of virus infections
DK198800927A DK172617B1 (da) 1986-07-04 1988-02-23 Ny medicinsk anvendelse af nukleosider
US07/319,840 US6358934B1 (en) 1986-07-04 1989-03-07 Anti-retroviral activity of 2′,3′-dideoxy-3′-fluoronucleosides
US08/118,356 US5446029A (en) 1986-07-04 1993-09-09 Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8602981A SE8602981D0 (sv) 1986-07-04 1986-07-04 Novel medicinal use

Publications (1)

Publication Number Publication Date
SE8602981D0 true SE8602981D0 (sv) 1986-07-04

Family

ID=20365027

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602981A SE8602981D0 (sv) 1986-07-04 1986-07-04 Novel medicinal use

Country Status (10)

Country Link
US (1) US6358934B1 (sv)
EP (1) EP0277151B1 (sv)
JP (1) JP2540576B2 (sv)
AT (1) ATE68349T1 (sv)
AU (1) AU598575B2 (sv)
CA (1) CA1286991C (sv)
DE (1) DE3773892D1 (sv)
DK (1) DK172617B1 (sv)
SE (1) SE8602981D0 (sv)
WO (1) WO1988000050A1 (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
SE9800452D0 (sv) * 1998-02-13 1998-02-13 Medivir Ab Antivirals
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
US5506215A (en) * 1987-11-03 1996-04-09 Medivir Ab 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides
GB8726136D0 (en) * 1987-11-07 1987-12-09 Wellcome Found Therapeutic nucleosides
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
US5157114A (en) * 1988-08-19 1992-10-20 Burroughs Wellcome Co. 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
GB9003543D0 (en) * 1990-02-16 1990-04-11 Wellcome Found Therapeutic nucleosides
GB9200150D0 (en) * 1992-01-06 1992-02-26 Wellcome Found Therapeutic nucleosides
US5663154A (en) * 1992-01-06 1997-09-02 Glaxo Wellcome Inc. 2',3'-dideoxy-3'-fluoro-purine ribonucleosides
US5360714A (en) * 1992-08-28 1994-11-01 Fox Chase Cancer Center Hepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereof
US5334525A (en) * 1992-08-28 1994-08-02 Fox Chase Cancer Center Hepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereof
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
DE69533856T2 (de) * 1994-10-24 2005-12-08 Genencor International, Inc., Palo Alto L-pyranosyl-nukleoside
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
AU728892B2 (en) * 1997-08-15 2001-01-18 Medivir Ab Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase of hepatitis B virus (HBV)
AU2003239088B2 (en) * 2002-06-27 2006-11-02 Medivir Ab Synergistic interaction of abacavir and alovudine
EP1610781A1 (en) 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of tipranavir and a further antiretroviral compound
WO2004087140A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
WO2004087169A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of nevirapine and a further antiretroviral compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
DD139793A1 (de) * 1978-11-06 1980-01-23 Waltraud Braun Mittel gegen psoriasis
DD158903A1 (de) * 1981-05-18 1983-02-09 Gotthard Kowollik Verfahren zur herstellung von 3'-fluor-2',3'-didesoxyadenosin
DD209197A1 (de) * 1981-07-21 1984-04-25 Akad Wissenschaften Ddr Verfahren zur herstellung von 3'-fluor-2',3'-didesoxyguanosin
US4724232A (en) 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
ATE108794T1 (de) * 1985-05-15 1994-08-15 Wellcome Found Therapeutische nucleoside und deren herstellung.
EP0258412A1 (en) 1986-02-20 1988-03-09 GREER, Sheldon B. Composition for and method of treating aids and certain related diseases

Also Published As

Publication number Publication date
DK92788D0 (da) 1988-02-23
AU7700587A (en) 1988-01-29
EP0277151B1 (en) 1991-10-16
AU598575B2 (en) 1990-06-28
ATE68349T1 (de) 1991-11-15
JP2540576B2 (ja) 1996-10-02
DK92788A (da) 1988-02-23
US6358934B1 (en) 2002-03-19
CA1286991C (en) 1991-07-30
WO1988000050A1 (en) 1988-01-14
DE3773892D1 (de) 1991-11-21
DK172617B1 (da) 1999-03-01
JPH01500193A (ja) 1989-01-26
EP0277151A1 (en) 1988-08-10

Similar Documents

Publication Publication Date Title
SE8602981D0 (sv) Novel medicinal use
DK602988A (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
ATE219366T1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
FI862011A0 (fi) Terapeutiska nukleosider.
ES2133138T3 (es) Nucleosidos terapeuticos.
DK275488D0 (da) Indolonderivater
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
DK524788A (da) Anvendelse af morphin-antagonister til fremstilling af laegemidler med immunomodulerende og antiviral effekt, isaer til behandling af erhvervede immundefekt-tilstande
DE69823984D1 (de) Synthese und anti-hiv und anti-hepatitis virus aktivität von 1,3-oxaselenolan nucleosiden
MX9203217A (es) Nucleosidos terapeuticos.
PT777669E (pt) Utilizacao de succinato de 4-(2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-ciclopenteno-1-metanol como agente antiviral
DK707988D0 (da) Fremgangsmaade til at haemme virus
MY105855A (en) Therapeutic nucleotides.
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
RU93058325A (ru) Применение производных 1,3-оксатиолана для получения лекарственных препаратов для лечения или профилактики вирусной инфекции гепатита в, применение производных 1,3 - оксатиолана для лечения инфекций гепатита в, способ лечения гепатита в
MY137298A (en) Therapeutic nucleosides
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
IT1225262B (it) Metodo per la sensibilizzazione di piccoli animali all'infezione da virus dell'immunodeficienza umana (hiv)
MY113560A (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b